Skip to main content
logo
Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.660
0.00 (0.00%)
At close: May 22, 2026, 4:00 PM EDT
2.690
+0.030 (1.13%)
After-hours: May 22, 2026, 7:55 PM EDT

Organogenesis Holdings Revenue

Organogenesis Holdings had revenue of $37.23M in the quarter ending March 31, 2026, a decrease of -57.06%. This brings the company's revenue in the last twelve months to $514.70M, up 12.19% year-over-year. In the year 2025, Organogenesis Holdings had annual revenue of $564.17M with 17.04% growth.

Revenue (ttm)
$514.70M
Revenue Growth
+12.19%
P/S Ratio
0.66
Revenue / Employee
$602,698
Employees
854
Market Cap
342.27M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025564.17M82.13M17.04%
Dec 31, 2024482.04M48.90M11.29%
Dec 31, 2023433.14M-17.75M-3.94%
Dec 31, 2022450.89M-16.47M-3.52%
Dec 31, 2021467.36M129.06M38.15%
Dec 31, 2020338.30M77.32M29.63%
Dec 31, 2019260.98M67.53M34.91%
Dec 31, 2018193.45M-5.06M-2.55%
Dec 31, 2017198.51M59.78M43.09%
Dec 31, 2016138.73M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Tilray Brands858.28M
Emergent BioSolutions676.80M
Evolus301.79M
Aurora Cannabis272.13M
Akebia Therapeutics232.40M
Canopy Growth203.04M
Kamada181.68M
Anika Therapeutics116.26M
Revenue Rankings

ORGO News

More News